Total Payments
$207.21
2021 Payments
$207.21
Companies
6
Transactions
13
Medicare Patients
797
Medicare Billing
$34,257
Payment Breakdown by Category
Food & Beverage$207.21 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $207.21 | 13 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $82.09 | 5 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $44.71 | 3 | $0 (2021) |
| kaleo, Inc. | $36.10 | 2 | $0 (2021) |
| ALK-Abello, Inc | $15.74 | 1 | $0 (2021) |
| Teva Pharmaceuticals USA, Inc. | $15.58 | 1 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $12.99 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $207.21 | 13 | GlaxoSmithKline, LLC. ($82.09) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/23/2021 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: Respiratory | ||||||
| 06/08/2021 | Teva Pharmaceuticals USA, Inc. | CINQAIR (Biological) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: Respiratory | ||||||
| 06/02/2021 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $12.08 | General |
| Category: IMMUNOLOGY | ||||||
| 05/26/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA (Drug) | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: RESPIRATORY | ||||||
| 05/17/2021 | kaleo, Inc. | AUVI-Q (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: ALLERGY | ||||||
| 05/05/2021 | ALK-Abello, Inc | TIMOTHY, STANDARDIZED (Biological), STANDARDIZED MITE D. FARINAE, ALTERNARIA TENUIS | Food and Beverage | In-kind items and services | $15.74 | General |
| 04/21/2021 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: IMMUNOLOGY | ||||||
| 04/19/2021 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: Respiratory | ||||||
| 04/02/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: RESPIRATORY | ||||||
| 03/31/2021 | kaleo, Inc. | AUVI-Q (Drug) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: ALLERGY | ||||||
| 03/10/2021 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: IMMUNOLOGY | ||||||
| 01/20/2021 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: IMMUNOLOGY | ||||||
| 01/05/2021 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $13.02 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 381 | 400 | $55,279 | $16,315 |
| 2022 | 12 | 401 | 422 | $60,232 | $17,013 |
| 2021 | 1 | 15 | 15 | $2,587 | $929.82 |
Total Patients
797
Total Services
837
Medicare Billing
$34,257
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 115 | 124 | $22,811 | $6,091 | 26.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 51 | 51 | $11,631 | $3,042 | 26.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 29 | 31 | $8,067 | $2,478 | 30.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $5,081 | $1,435 | 28.3% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 25 | 26 | $2,340 | $900.12 | 38.5% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 15 | 17 | $1,104 | $828.27 | 75.0% |
| 87430 | Detection test by immunoassay technique for streptococcus, group a (strep) | Office | 2023 | 33 | 36 | $1,271 | $579.74 | 45.6% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 29 | 29 | $2,011 | $562.95 | 28.0% |
| 80047 | Blood test, basic group of blood chemicals (calcium, ionized) | Office | 2023 | 14 | 14 | $403.62 | $171.87 | 42.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 11 | 11 | $323.84 | $90.74 | 28.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 33 | 35 | $165.55 | $72.85 | 44.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 11 | 11 | $69.30 | $62.37 | 90.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 85 | 91 | $13,559 | $4,759 | 35.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 67 | 67 | $14,606 | $4,053 | 27.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 45 | 45 | $9,765 | $2,604 | 26.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 27 | 27 | $8,910 | $2,066 | 23.2% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 32 | 32 | $3,264 | $973.65 | 29.8% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 23 | 23 | $2,070 | $801.95 | 38.7% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 14 | 28 | $693.00 | $458.10 | 66.1% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 24 | 24 | $3,216 | $457.47 | 14.2% |
| 87430 | Detection test by immunoassay technique for streptococcus, group a (strep) | Office | 2022 | 26 | 26 | $1,482 | $412.94 | 27.9% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2022 | 12 | 12 | $678.00 | $197.34 | 29.1% |
| 80047 | Blood test, basic group of blood chemicals (calcium, ionized) | Office | 2022 | 12 | 12 | $1,044 | $151.80 | 14.5% |
| 81003 | Automated urinalysis test | Office | 2022 | 34 | 35 | $945.00 | $77.70 | 8.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 15 | 15 | $2,587 | $929.82 | 35.9% |
About Katelyn Patterson, NP-C
Katelyn Patterson, NP-C is a Family healthcare provider based in Ranson, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/05/2020. The National Provider Identifier (NPI) number assigned to this provider is 1275147324.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Katelyn Patterson, NP-C has received a total of $207.21 in payments from pharmaceutical and medical device companies, with $207.21 received in 2021. These payments were reported across 13 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($207.21).
As a Medicare-enrolled provider, Patterson has provided services to 797 Medicare beneficiaries, totaling 837 services with total Medicare billing of $34,257. Data is available for 3 years (2021–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Other Specialties Family
- Location Ranson, WV
- Active Since 09/05/2020
- Last Updated 09/23/2025
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1275147324
Products in Payments
- NUCALA (Biological) $64.51
- FASENRA (Biological) $44.71
- AUVI-Q (Drug) $36.10
- TRELEGY ELLIPTA (Drug) $17.58
- TIMOTHY, STANDARDIZED (Biological) $15.74
- CINQAIR (Biological) $15.58
- SPIRIVA (Drug) $12.99
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Ranson
Martina Best, Np, NP
Family — Payments: $1,553
Family $1,553
Paige Andersen, Np, NP
Family — Payments: $97.44
Family $97.44
Gerald Oliver, Fnp-C, FNP-C
Family — Payments: $89.54
Family $89.54
Donna-Sue Lammie, Np, NP
Family — Payments: $67.06
Family $67.06
Leona Cook
Family
Family
Eugenia Johnson, Fnp-Bc, FNP-BC
Family
Family